| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Original Research Communications |
1 From the Department of Medicine, The University of Western Australia and The West Australian Heart Research Institute, Perth, and the Department of Medicine, University of Melbourne and St Vincent's Hospital, Melbourne.
Background: Regular consumption of n-3 fatty acids of marine origin can improve serum lipids and reduce cardiovascular risk.
Objective: This study aimed to determine whether eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids have differential effects on serum lipids and lipoproteins, glucose, and insulin in humans.
Design: In a double-blind, placebo-controlled trial of parallel design, 59 overweight, nonsmoking, mildly hyperlipidemic men were randomly assigned to receive 4 g purified EPA, DHA, or olive oil (placebo) daily while continuing their usual diets for 6 wk.
Results: Fifty-six men aged 48.8 ± 1.1 y completed the study. Relative to those in the olive oil group, triacylglycerols fell by 0.45 ± 0.15 mmol/L (
20%; P = 0.003) in the DHA group and by 0.37 ± 0.14 mmol/L (18%; P = 0.012) in the EPA group. Neither EPA nor DHA had any effect on total cholesterol. LDL, HDL, and HDL2 cholesterol were not affected significantly by EPA, but HDL3 cholesterol decreased significantly (6.7%; P = 0.032). Although HDL cholesterol was not significantly increased by DHA (3.1%), HDL2 cholesterol increased by 29% (P = 0.004). DHA increased LDL cholesterol by 8% (P = 0.019). Adjusted LDL particle size increased by 0.25 ± 0.08 nm (P = 0.002) with DHA but not with EPA. EPA supplementation increased plasma and platelet phospholipid EPA but reduced DHA. DHA supplementation increased DHA and EPA in plasma and platelet phospholipids. Both EPA and DHA increased fasting insulin significantly. EPA, but not DHA, tended to increase fasting glucose, but not significantly so.
Conclusions: EPA and DHA had differential effects on lipids, fatty acids, and glucose metabolism in overweight men with mild hyperlipidemia.
Key Words: Eicosapentaenoic acid • docosahexaenoic acid • EPA • DHA • hyperlipidemia • fish oil • n-3 fatty acids • lipids • LDL particle size • glucose metabolism • insulin metabolism • men
This article has been cited by other articles:
|
|
 |
|
  C. A. Goodman, D. Horvath, C. Stathis, T. Mori, K. Croft, R. M. Murphy, and A. Hayes Taurine supplementation increases skeletal muscle force production and protects muscle function during and after high-frequency in vitro stimulation J Appl Physiol, July 1, 2009; 107(1): 144 - 154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Rajaram, E. H. Haddad, A. Mejia, and J. Sabate Walnuts and fatty fish influence different serum lipid fractions in normal to mildly hyperlipidemic individuals: a randomized controlled study Am. J. Clinical Nutrition, May 1, 2009; 89(5): 1657S - 1663S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Egert, F. Kannenberg, V. Somoza, H. F. Erbersdobler, and U. Wahrburg Dietary {alpha}-Linolenic Acid, EPA, and DHA Have Differential Effects on LDL Fatty Acid Composition but Similar Effects on Serum Lipid Profiles in Normolipidemic Humans J. Nutr., May 1, 2009; 139(5): 861 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Barcelo-Coblijn, E. J Murphy, R. Othman, M. H Moghadasian, T. Kashour, and J. K Friel Flaxseed oil and fish-oil capsule consumption alters human red blood cell n-3 fatty acid composition: a multiple-dosing trial comparing 2 sources of n-3 fatty acid Am. J. Clinical Nutrition, September 1, 2008; 88(3): 801 - 809. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Higashihara, K. Nutahara, S. Horie, S. Muto, T. Hosoya, K. Hanaoka, K. Tuchiya, K. Kamura, K. Takaichi, Y. Ubara, et al. The effect of eicosapentaenoic acid on renal function and volume in patients with ADPKD Nephrol. Dial. Transplant., September 1, 2008; 23(9): 2847 - 2852. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Micallef and M. L. Garg The Lipid-Lowering Effects of Phytosterols and (n-3) Polyunsaturated Fatty Acids Are Synergistic and Complementary in Hyperlipidemic Men and Women J. Nutr., June 1, 2008; 138(6): 1086 - 1090. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Kelley, D. Siegel, M. Vemuri, G. H. Chung, and B. E. Mackey Docosahexaenoic Acid Supplementation Decreases Remnant-Like Particle-Cholesterol and Increases the (n-3) Index in Hypertriglyceridemic Men J. Nutr., January 1, 2008; 138(1): 30 - 35. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. K. Gabler, J. D. Spencer, D. M. Webel, and M. E. Spurlock In Utero and Postnatal Exposure to Long Chain (n-3) PUFA Enhances Intestinal Glucose Absorption and Energy Stores in Weanling Pigs J. Nutr., November 1, 2007; 137(11): 2351 - 2358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Vuksan, D. Whitham, J. L. Sievenpiper, A. L. Jenkins, A. L. Rogovik, R. P. Bazinet, E. Vidgen, and A. Hanna Supplementation of Conventional Therapy With the Novel Grain Salba (Salvia hispanica L.) Improves Major and Emerging Cardiovascular Risk Factors in Type 2 Diabetes: Results of a randomized controlled trial Diabetes Care, November 1, 2007; 30(11): 2804 - 2810. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S Kelley, D. Siegel, M. Vemuri, and B. E Mackey Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men Am. J. Clinical Nutrition, August 1, 2007; 86(2): 324 - 333. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M Hill, J. D Buckley, K. J Murphy, and P. R. Howe Combining fish-oil supplements with regular aerobic exercise improves body composition and cardiovascular disease risk factors Am. J. Clinical Nutrition, May 1, 2007; 85(5): 1267 - 1274. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Demonty, Y.-M. Chan, D. Pelled, and P. J. Jones Fish-oil esters of plant sterols improve the lipid profile of dyslipidemic subjects more than do fish-oil or sunflower oil esters of plant sterols Am. J. Clinical Nutrition, December 1, 2006; 84(6): 1534 - 1542. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M Arterburn, E. B. Hall, and H. Oken Distribution, interconversion, and dose response of n-3 fatty acids in humans Am. J. Clinical Nutrition, June 1, 2006; 83(6): S1467 - 1476S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Varady and P. J. H. Jones Combination Diet and Exercise Interventions for the Treatment of Dyslipidemia: an Effective Preliminary Strategy to Lower Cholesterol Levels? J. Nutr., August 1, 2005; 135(8): 1829 - 1835. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. A Castro, L. P Barroso, and P. Sinnecker Functional foods for coronary heart disease risk reduction: a meta-analysis using a multivariate approach Am. J. Clinical Nutrition, July 1, 2005; 82(1): 32 - 40. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. C. Maki, M. E. Van Elswyk, D. McCarthy, S. P. Hess, P. E. Veith, M. Bell, P. Subbaiah, and M. H. Davidson Lipid Responses to a Dietary Docosahexaenoic Acid Supplement in Men and Women with Below Average Levels of High Density Lipoprotein Cholesterol J. Am. Coll. Nutr., June 1, 2005; 24(3): 189 - 199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Sekikawa, H. Ueshima, W. R. Zaky, T. Kadowaki, D. Edmundowicz, T. Okamura, K. Sutton-Tyrrell, Y. Nakamura, K. Egawa, H. Kanda, et al. Much lower prevalence of coronary calcium detected by electron-beam computed tomography among men aged 40-49 in Japan than in the US, despite a less favorable profile of major risk factors Int. J. Epidemiol., February 1, 2005; 34(1): 173 - 179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D Stark and B. J Holub Differential eicosapentaenoic acid elevations and altered cardiovascular disease risk factor responses after supplementation with docosahexaenoic acid in postmenopausal women receiving and not receiving hormone replacement therapy Am. J. Clinical Nutrition, May 1, 2004; 79(5): 765 - 773. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. E Theobald, P. J Chowienczyk, R. Whittall, S. E Humphries, and T. A. Sanders LDL cholesterol-raising effect of low-dose docosahexaenoic acid in middle-aged men and women Am. J. Clinical Nutrition, April 1, 2004; 79(4): 558 - 563. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kew, M. D Mesa, S. Tricon, R. Buckley, A. M Minihane, and P. Yaqoob Effects of oils rich in eicosapentaenoic and docosahexaenoic acids on immune cell composition and function in healthy humans Am. J. Clinical Nutrition, April 1, 2004; 79(4): 674 - 681. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. E Finnegan, A. M Minihane, E. C Leigh-Firbank, S. Kew, G. W Meijer, R. Muggli, P. C Calder, and C. M Williams Plant- and marine-derived n-3 polyunsaturated fatty acids have differential effects on fasting and postprandial blood lipid concentrations and on the susceptibility of LDL to oxidative modification in moderately hyperlipidemic subjects Am. J. Clinical Nutrition, April 1, 2003; 77(4): 783 - 795. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Park and W. S. Harris Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance J. Lipid Res., March 1, 2003; 44(3): 455 - 463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C Chan, G. F Watts, T. A Mori, P H. R Barrett, T. G Redgrave, and L. J Beilin Randomized controlled trial of the effect of n-3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity Am. J. Clinical Nutrition, February 1, 2003; 77(2): 300 - 307. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Woodman, T. A. Mori, V. Burke, I. B. Puddey, G. F. Watts, J. D. Best, and L. J. Beilin Docosahexaenoic Acid But Not Eicosapentaenoic Acid Increases LDL Particle Size in Treated Hypertensive Type 2 Diabetic Patients Diabetes Care, January 1, 2003; 26(1): 253 - 253. [Full Text] [PDF]
|
|
|
|
|
|
R. J Woodman, T. A Mori, V. Burke, I. B Puddey, G. F Watts, and L. J Beilin Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension Am. J. Clinical Nutrition, November 1, 2002; 76(5): 1007 - 1015. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Chan, G. F. Watts, P. H. R. Barrett, L. J. Beilin, T. G. Redgrave, and T. A. Mori Regulatory Effects of HMG CoA Reductase Inhibitor and Fish Oils on Apolipoprotein B-100 Kinetics in Insulin-Resistant Obese Male Subjects With Dyslipidemia Diabetes, August 1, 2002; 51(8): 2377 - 2386. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Chan, G. F. Watts, P. H. R. Barrett, L. J. Beilin, and T. A. Mori Effect of Atorvastatin and Fish Oil on Plasma High-Sensitivity C-Reactive Protein Concentrations in Individuals with Visceral Obesity Clin. Chem., June 1, 2002; 48(6): 877 - 883. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Vasandani, A. I. Kafrouni, A. Caronna, Y. Bashmakov, M. Gotthardt, J. D. Horton, and D. K. Spady Upregulation of hepatic LDL transport by n-3 fatty acids in LDL receptor knockout mice J. Lipid Res., May 1, 2002; 43(5): 772 - 784. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. B. Jump The Biochemistry of n-3 Polyunsaturated Fatty Acids J. Biol. Chem., March 8, 2002; 277(11): 8755 - 8758. [Full Text] [PDF]
|
|
|
|
|
|
E. Dewailly, C. Blanchet, S. Gingras, S. Lemieux, L. Sauve, J. Bergeron, and B. J. Holub Relations between n-3 fatty acid status and cardiovascular disease risk factors among Quebecers Am. J. Clinical Nutrition, November 1, 2001; 74(5): 603 - 611. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R. Harper and T. A. Jacobson The Fats of Life: The Role of Omega-3 Fatty Acids in the Prevention of Coronary Heart Disease Arch Intern Med, October 8, 2001; 161(18): 2185 - 2192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Dewailly, C. Blanchet, S. Lemieux, L. Sauve, S. Gingras, P. Ayotte, and B. J. Holub n-3 Fatty acids and cardiovascular disease risk factors among the Inuit of Nunavik Am. J. Clinical Nutrition, October 1, 2001; 74(4): 464 - 473. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
